- Home
- FUNC vs IRWD Comparison
FUNC vs IRWD Comparison
Compare FUNC & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUNC
- IRWD
- Stock Information
- Founded
- FUNC 1900
- IRWD 1998
- Country
- FUNC United States
- IRWD United States
- Employees
- FUNC N/A
- IRWD N/A
- Industry
- FUNC Major Banks
- IRWD Biotechnology: Pharmaceutical Preparations
- Sector
- FUNC Finance
- IRWD Health Care
- Exchange
- FUNC Nasdaq
- IRWD Nasdaq
- Market Cap
- FUNC N/A
- IRWD 150.9M
- IPO Year
- FUNC N/A
- IRWD 2010
- Fundamental
- Price
- FUNC $30.90
- IRWD $0.71
- Analyst Decision
- FUNC
- IRWD Buy
- Analyst Count
- FUNC 0
- IRWD 5
- Target Price
- FUNC N/A
- IRWD $4.94
- AVG Volume (30 Days)
- FUNC 14.4K
- IRWD 4.2M
- Earning Date
- FUNC 04-21-2025
- IRWD 05-07-2025
- Dividend Yield
- FUNC 2.76%
- IRWD N/A
- EPS Growth
- FUNC 61.82
- IRWD N/A
- EPS
- FUNC 3.49
- IRWD N/A
- Revenue
- FUNC $79,403,000.00
- IRWD $317,676,000.00
- Revenue This Year
- FUNC $14.15
- IRWD N/A
- Revenue Next Year
- FUNC $7.07
- IRWD N/A
- P/E Ratio
- FUNC $9.15
- IRWD N/A
- Revenue Growth
- FUNC 14.92
- IRWD N/A
- 52 Week Low
- FUNC $19.17
- IRWD $0.59
- 52 Week High
- FUNC $42.50
- IRWD $8.23
- Technical
- Relative Strength Index (RSI)
- FUNC 59.68
- IRWD 29.40
- Support Level
- FUNC $30.13
- IRWD $0.88
- Resistance Level
- FUNC $31.45
- IRWD $0.98
- Average True Range (ATR)
- FUNC 0.77
- IRWD 0.10
- MACD
- FUNC 0.32
- IRWD 0.02
- Stochastic Oscillator
- FUNC 100.00
- IRWD 11.74
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.